A cross-species analysis method to analyze animal models' similarity to human's disease state

BMC Systems Biology

Volumn 6, Issue SUPPL3, 2012, Pages

  Yu, Shuhao ^a   Zheng, Lulu ^d,e   Li, Yun ^b   Li, Chunyan ^c   Ma, Chenchen ^b   Li, Yixue ^a,b,e   Li, Xuan ^b   Hao, Pei ^c,e  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ALZHEIMER DISEASE; ANIMAL; ANOXIA; ARTICLE; CELL STRAIN 3T3; COMPARATIVE STUDY; DIABETES MELLITUS; DISEASE MODEL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC DATABASE; GENETICS; HUMAN; METHODOLOGY; MICROARRAY ANALYSIS; MOUSE; PATHOLOGY; SYSTEMS BIOLOGY;

3T3 CELLS; ALGORITHMS; ALZHEIMER DISEASE; ANIMALS; ANOXIA; DATABASES, GENETIC; DIABETES MELLITUS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; MICE; MICROARRAY ANALYSIS; SYSTEMS BIOLOGY;

MLCS; MLOWN;

EID: 84878830778     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-6-S3-S18     Document Type: Article

References (53)

1. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 2009, 15(3):331-337. 10.1038/nm.1912, 2838375, 19198615.
2. Chin J. Selecting a mouse model of Alzheimer's disease. Methods Mol Biol 2011, 670:169-189.
3. Miller JA, Horvath S, Geschwind DH. Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc Natl Acad Sci USA 2010, 107(28):12698-12703. 10.1073/pnas.0914257107, 2906579, 20616000.
4. Haldar M, Hancock JD, Coffin CM, Lessnick SL, Capecchi MR. A conditional mouse model of synovial sarcoma: insights into a myogenic origin. Cancer Cell 2007, 11(4):375-388. 10.1016/j.ccr.2007.01.016, 17418413.
5. Hung KE, Maricevich MA, Richard LG, Chen WY, Richardson MP, Kunin A, Bronson RT, Mahmood U, Kucherlapati R. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proc Natl Acad Sci U S A 2010, 107:1565-1570. 10.1073/pnas.0908682107, 2824379, 20080688.
6. Raab M, Kappel S, Kramer A, Sanhaji M, Matthess Y, Kurunci-Csacsko E, Calzada-Wack J, Rathkolb B, Rozman J, Adler T, et al. Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells. Nat Commun 2011, 2:395. 3144583, 21772266.
7. Chakraborty C, Hsu CH, Wen ZH, Lin CS, Agoramoorthy G. Zebrafish: a complete animal model for in vivo drug discovery and development. Curr Drug Metab 2009, 10(2):116-124. 10.2174/138920009787522197, 19275547.
8. Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005, 4(1):35-44. 10.1038/nrd1606, 15688071.
9. Kari G, Rodeck U, Dicker AP. Zebrafish: an emerging model system for human disease and drug discovery. Clin Pharmacol Ther 2007, 82(1):70-80. 10.1038/sj.clpt.6100223, 17495877.
10. Singh M, Johnson L. Using Genetically Engineered Mouse Models of Cancer to Aid Drug Development: An Industry Perspective. Clinical Cancer Research 2006, 12(18):5312-5328. 10.1158/1078-0432.CCR-06-0437, 17000664.
11. Sharpless NE, Depinho RA. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 2006, 5(9):741-754. 10.1038/nrd2110, 16915232.
12. Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 2000, 32(1):56-67. 10.1006/rtph.2000.1399, 11029269.
13. Strand AD, Aragaki AK, Baquet ZC, Hodges A, Cunningham P, Holmans P, Jones KR, Jones L, Kooperberg C, Olson JM. Conservation of regional gene expression in mouse and human brain. PLoS Genet 2007, 3(4):e59. 10.1371/journal.pgen.0030059, 1853119, 17447843.
14. Dowell RD. The similarity of gene expression between human and mouse tissues. Genome Biol 2011, 12(1):101. 10.1186/gb-2011-12-1-101, 3091293, 21241524.
15. Zheng-Bradley X, Rung J, Parkinson H, Brazma A. Large scale comparison of global gene expression patterns in human and mouse. Genome Biol 2010, 11(12):R124. 10.1186/gb-2010-11-12-r124, 3046484, 21182765.
16. Chan ET, Quon GT, Chua G, Babak T, Trochesset M, Zirngibl RA, Aubin J, Ratcliffe MJ, Wilde A, Brudno M, et al. Conservation of core gene expression in vertebrate tissues. J Biol 2009, 8(3):33. 10.1186/jbiol130, 2689434, 19371447.
17. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006, 313(5795):1929-1935. 10.1126/science.1132939, 17008526.
18. Deluca TF, Wu IH, Pu J, Monaghan T, Peshkin L, Singh S, Wall DP. Roundup: a multi-genome repository of orthologs and evolutionary distances. Bioinformatics 2006, 22(16):2044-2046. 10.1093/bioinformatics/btl286, 16777906.
19. Li Y, Hao P, Zheng S, Tu K, Fan H, Zhu R, Ding G, Dong C, Wang C, Li X, et al. Gene expression module-based chemical function similarity search. Nucleic Acids Res 2008, 36(20):e137. 10.1093/nar/gkn610, 2582597, 18842630.
20. Dowdell KC, Pesnicak L, Hoffmann V, Steadman K, Remaley AT, Cohen JI, Straus SE, Rao VK. Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS). Exp Hematol 2009, 37(4):487-494. 10.1016/j.exphem.2008.12.002, 2693256, 19217201.
21. Hrzenjak A, Moinfar F, Kremser ML, Strohmeier B, Petru E, Zatloukal K, Denk H. Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo. Mol Cancer 2010, 9:49. 10.1186/1476-4598-9-49, 2843655, 20202195.
22. Baidyaroy D, Brosch G, Graessle S, Trojer P, Walton JD. Characterization of inhibitor-resistant histone deacetylase activity in plant-pathogenic fungi. Eukaryot Cell 2002, 1(4):538-547. 10.1128/EC.1.4.538-547.2002, 118000, 12456002.
23. Dudley JT, Tibshirani R, Deshpande T, Butte AJ. Disease signatures are robust across tissues and experiments. Mol Syst Biol 2009, 5:307. 2758720, 19756046.
24. Laifenfeld D, Gilchrist A, Drubin D, Jorge M, Eddy SF, Frushour BP, Ladd B, Obert LA, Gosink MM, Cook JC, et al. The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma. Toxicol Sci 2010, 113(1):254-266. 10.1093/toxsci/kfp213, 2794330, 19812364.
25. Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J, Le AD. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther 2005, 4(10):1465-1474. 10.1158/1535-7163.MCT-05-0198, 16227395.
26. Li Y, Zhang JF, Zhang YM, Ma XB. The protective effect of genistein postconditioning on hypoxia/reoxygenation-induced injury in human gastric epithelial cells. Acta Pharmacol Sin 2009, 30(5):576-581. 10.1038/aps.2009.29, 19349965.
27. Sohaskey CD. Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration. J Bacteriol 2008, 190(8):2981-2986. 10.1128/JB.01857-07, 2293237, 18296525.
28. Vengellur A, Phillips JM, Hogenesch JB, LaPres JJ. Gene expression profiling of hypoxia signaling in human hepatocellular carcinoma cells. Physiol Genomics 2005, 22(3):308-318. 10.1152/physiolgenomics.00045.2004, 15942021.
29. Yamamoto S, Tanaka E, Higashi H. Mediation by intracellular calcium-dependent signals of hypoxic hyperpolarization in rat hippocampal CA1 neurons in vitro. J Neurophysiol 1997, 77(1):386-392.
30. Edelstein CL, Yaqoob MM, Alkhunaizi AM, Gengaro PE, Nemenoff RA, Wang KK, Schrier RW. Modulation of hypoxia-induced calpain activity in rat renal proximal tubules. Kidney Int 1996, 50(4):1150-1157. 10.1038/ki.1996.422, 8887272.
31. Carver DJ, Gaston B, Deronde K, Palmer LA. Akt-mediated activation of HIF-1 in pulmonary vascular endothelial cells by S-nitrosoglutathione. Am J Respir Cell Mol Biol 2007, 37(3):255-263. 10.1165/rcmb.2006-0289SM, 1994227, 17541013.
32. Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, Kaper F, Giaccia AJ, Abraham RT. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 2002, 22(20):7004-7014. 10.1128/MCB.22.20.7004-7014.2002, 139825, 12242281.
33. Kambe T, Tada-Kambe J, Kuge Y, Yamaguchi-Iwai Y, Nagao M, Sasaki R. Retinoic acid stimulates erythropoietin gene transcription in embryonal carcinoma cells through the direct repeat of a steroid/thyroid hormone receptor response element half-site in the hypoxia-response enhancer. Blood 2000, 96(9):3265-3271.
34. Tuller ER, Beavers CT, Lou JR, Ihnat MA, Benbrook DM, Ding WQ. Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: the involvement of peroxisome proliferator-activated receptor alpha and hypoxia-inducible factor-2alpha signaling. Mol Pharmacol 2009, 76(3):588-595. 10.1124/mol.109.057430, 19528198.
35. Schlenker EH. In hamsters dopamine D2 receptors affect ventilation during and following intermittent hypoxia. Comp Biochem Physiol A Mol Integr Physiol 2007, 148(3):674-680. 10.1016/j.cbpa.2007.08.020, 2083261, 17884646.
36. Mottet D, Michel G, Renard P, Ninane N, Raes M, Michiels C. Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J Cell Physiol 2003, 194(1):30-44. 10.1002/jcp.10176, 12447987.
37. Beitner-Johnson D, Rust RT, Hsieh TC, Millhorn DE. Hypoxia activates Akt and induces phosphorylation of GSK-3 in PC12 cells. Cell Signal 2001, 13(1):23-27. 10.1016/S0898-6568(00)00128-5, 11257444.
38. Ramasamy R, Goldberg IJ. Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. Circ Res 2010, 106(9):1449-1458. 10.1161/CIRCRESAHA.109.213447, 2882633, 20466987.
39. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 1995, 83(5):803-812. 10.1016/0092-8674(95)90193-0, 8521497.
40. Murphy GJ, Holder JC. PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci 2000, 21(12):469-474. 10.1016/S0165-6147(00)01559-5, 11121836.
41. Kayali AG, Austin DA, Webster NJ. Rottlerin inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes by uncoupling mitochondrial oxidative phosphorylation. Endocrinology 2002, 143(10):3884-3896. 10.1210/en.2002-220259, 12239100.
42. Zhang D, Xu L, Cao F, Wei T, Yang C, Uzan G, Peng B. Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way. Cell Stress Chaperones 2010, 15(6):939-946. 10.1007/s12192-010-0202-1, 3024068, 20480272.
43. Shudo K, Fukasawa H, Nakagomi M, Yamagata N. Towards retinoid therapy for Alzheimer's disease. Curr Alzheimer Res 2009, 6(3):302-311. 10.2174/156720509788486581, 2765081, 19519313.
44. Valles SL, Dolz-Gaiton P, Gambini J, Borras C, Lloret A, Pallardo FV, Vina J. Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPAR gamma expression in cultured astrocytes. Brain Res 2010, 1312:138-144.
45. Luo W, Rodina A, Chiosis G. Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?. BMC Neurosci 2008, 9(Suppl 2):S7. 10.1186/1471-2202-9-S2-S7, 2604885, 19091004.
46. Shineman DW, Dain AS, Kim ML, Lee VM. Constitutively active Akt inhibits trafficking of amyloid precursor protein and amyloid precursor protein metabolites through feedback inhibition of phosphoinositide 3-kinase. Biochemistry 2009, 48(17):3787-3794. 10.1021/bi802070j, 3021459, 19236051.
47. Wang LY, Shofer JB, Rohde K, Hart KL, Hoff DJ, McFall YH, Raskind MA, Peskind ER. Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression. Am J Geriatr Psychiatry 2009, 17(9):744-751. 10.1097/JGP.0b013e3181ab8c61, 2842091, 19700947.
48. Han G, Ma H, Chintala R, Fulton DJ, Barman SA, White RE. Essential role of the 90-kilodalton heat shock protein in mediating nongenomic estrogen signaling in coronary artery smooth muscle. J Pharmacol Exp Ther 2009, 329(3):850-855. 10.1124/jpet.108.149112, 2683768, 19293389.
49. Iorio F, Bosotti R, Scacheri E, Belcastro V, Mithbaokar P, Ferriero R, Murino L, Tagliaferri R, Brunetti-Pierri N, Isacchi A, et al. Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci USA 2010, 107(33):14621-14626. 10.1073/pnas.1000138107, 2930479, 20679242.
50. Fliss AE, Benzeno S, Rao J, Caplan AJ. Control of estrogen receptor ligand binding by Hsp90. J Steroid Biochem Mol Biol 2000, 72(5):223-230. 10.1016/S0960-0760(00)00037-6, 10822011.
51. Greenfield JP, Leung LW, Cai D, Kaasik K, Gross RS, Rodriguez-Boulan E, Greengard P, Xu H. Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J Biol Chem 2002, 277(14):12128-12136. 10.1074/jbc.M110009200, 11823458.
52. Schofield PN, Sundberg JP, Hoehndorf R, Gkoutos GV. New approaches to the representation and analysis of phenotype knowledge in human diseases and their animal models. Brief Funct Genomics 2011, 10(5):258-265. 10.1093/bfgp/elr031, 3189694, 21987712.
53. Wall DP, Fraser HB, Hirsh AE. Detecting putative orthologs. Bioinformatics 2003, 19(13):1710-1711. 10.1093/bioinformatics/btg213, 15593400.